NCDR Inpatient Registry Overview - RDN Registry - Non-CE-NCDR Inpatient Registry Overview - RDN Registry

NCDR Inpatient Registry Overview - RDN Registry - Non-CE

Video Transcription

Video Summary

The overview explains that renal denervation is an emerging minimally invasive treatment for uncontrolled or resistant hypertension. Because high blood pressure affects nearly 120 million U.S. adults and is often inadequately controlled, real-world evidence is needed. The RDN module was created to collect data across the patient journey, from baseline and procedure details to long-term follow-up. It supports quality improvement, benchmarking, research, and post-approval evidence generation. By tracking blood pressure and other outcomes over time, the registry helps evaluate safety, effectiveness, durability, and the future role of renal denervation in hypertension care.

Keywords

LAO Registry

Left Atrial Appendage Occlusion

Atrial Fibrillation

Stroke Prevention

Quality Improvement

renal denervation

resistant hypertension

blood pressure registry

real-world evidence

hypertension treatment